| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 12/27/2007 | US20070298121 Using compositions containing zinc ions, calcium ions, rubidium ions and/or potassium ions; modulates matrix metalloproteinases (MMPs), |
| 12/27/2007 | US20070298081 Alleviating acute alcohol intoxication/side effects of a hangover by administering, for example, 2,3-dimercapto-1-propanol; food additives/supplements; animal feed; oxidation resistance; immunostimulants; demetallization; shelf life cosmetology; dermatology; food additives/supplements; feeds; drugs |
| 12/27/2007 | US20070298058 Pharmaceutical compositions comprising ascomycin |
| 12/27/2007 | US20070298039 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases |
| 12/27/2007 | US20070298037 administering antagonist to ztnfr14 comprising antibodies, antibody fragments, proteins or polypeptides, for the treatment of psoriasis, inflammatory bowel disease or multiple sclerosis in mammals |
| 12/27/2007 | US20070298017 Composition for Treating Baldness with Stem Cell Derived From Umbilical Cord Blood |
| 12/27/2007 | US20070297999 Kit containing an acidic composition and a composition based on a hydroxyalkyl urea |
| 12/27/2007 | US20070297998 Surface-Modified Zinc-Titanium Mixed Oxides |
| 12/27/2007 | US20070297989 Novel anti-inflammatory androstane derivatives |
| 12/27/2007 | DE202007012343U1 Aminosäure-Mineral-Peptid-Komplex, insbesondere quantenmechanisch modifiziert, als Rezeptur zur Regulierung der Haut Amino acid-mineral-peptide complex, in particular quantum-mechanically modified, as formulation for regulating skin |
| 12/27/2007 | DE10196235B4 Using collagen from aquatic animals as carriers for tissue engineering, useful e.g. as skin replacements and in screening for antiaging drugs |
| 12/27/2007 | DE10033990B4 Nanopartikel aus einem substituierten Cyclodextrin, dessen Verwendung und diese enthaltenden Zubereitungen Nanoparticles consisting of a substituted cyclodextrin, its use and these preparations containing |
| 12/27/2007 | CA2656413A1 Oxo-substituted imidazo[1,2b]pyridazines, their preparation and use as pharmaceuticals |
| 12/27/2007 | CA2655788A1 Skin external preparation containing triterpenic acid |
| 12/27/2007 | CA2655014A1 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 12/26/2007 | EP1870465A2 Chemokine receptors 88-2B (CKR-3) and 88C and their antibodies |
| 12/26/2007 | EP1870413A1 Antipruritic agent for pruritus caused by multiple sclerosis |
| 12/26/2007 | EP1870402A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors |
| 12/26/2007 | EP1870110A1 Preparation comprising microparticles of complex composed of nucleic acid molecule and collagen |
| 12/26/2007 | EP1870105A1 Use of fucans in the treatment of psoriasis |
| 12/26/2007 | EP1870094A1 Antiwrinkle agent |
| 12/26/2007 | EP1868685A2 11ß-HYDROXYSTEROID DEHYDROGENASES |
| 12/26/2007 | EP1868618A2 Topical compositions comprising several mono- and/or oligosaccharides for treating skin diseases of warm blood hair coated animals. |
| 12/26/2007 | EP1868594A1 Ganglionic blocking agents for the treatment of epithelial diseases |
| 12/26/2007 | EP1345620B1 Stable enzymatic wound debrider |
| 12/26/2007 | EP1330999B1 Melanogenesis inhibitors and whitening agents comprising ergosterol derivative and compositions containing ergosterol derivative |
| 12/26/2007 | EP1235596B1 Use of lytic toxins and toxin conjugates |
| 12/26/2007 | CN200994929Y Anti-inflammatory wound paste |
| 12/26/2007 | CN101094676A Use of androgens to reduce the likelihood of acquiring or to treat skin aging |
| 12/26/2007 | CN101092409A C-aryl glucoside sglt2 inhibitors and method |
| 12/26/2007 | CN101091795A Prevention and treatment of synucleinopathic disease |
| 12/26/2007 | CN101091783A Preparation of Chinese traditional medicine for treating HIV infection, AIDS, tumours etc. multiple difficult diseases |
| 12/26/2007 | CN101091781A Plaster for treating mycotic infection, and preparation method |
| 12/26/2007 | CN101091779A Powder of bluestone for burn |
| 12/26/2007 | CN101091767A Anti-inflammation, dissolving lumps, and ease pain paste, and preparation method |
| 12/26/2007 | CN101091761A Medicine for treating recurrent beriberi |
| 12/26/2007 | CN101091760A Regeneration ointment for skin deteriment and preparation method |
| 12/26/2007 | CN101091757A Health food of possessing function for dispelling acne |
| 12/26/2007 | CN101091756A Liquor for treating trauma, burn and scald |
| 12/26/2007 | CN101091755A Medicine for treating tinea disease and skin disease, and preparation method |
| 12/26/2007 | CN101091750A Chinese traditional medicine of oral medication for treating heady urticaria |
| 12/26/2007 | CN101091741A Medicine of soaking feet in use for treating feet sweat disease and preparation method |
| 12/26/2007 | CN101091735A Gel preparation for treating subacute eczema and chronic eczema, and preparation method |
| 12/26/2007 | CN101091732A Medication of treating psoriasis |
| 12/26/2007 | CN101091729A Steaming and washing medication for treating eczema scroti and preparation method |
| 12/26/2007 | CN101091707A Medicinal usage of kuhseng extractive |
| 12/26/2007 | CN101091704A Method for preparing medicine dedicated for treating condyloma acuminatum |
| 12/26/2007 | CN101091690A Composition containing tioconazole in use for hair |
| 12/26/2007 | CN100357281C Bicyclic compounds, process for their preparation and pharmaceutical composition containing them |
| 12/26/2007 | CN100357276C Quinoline and quinoxaline compounds as PDGF-R and/or LCD tyrosine kinase inhibitors |
| 12/26/2007 | CN100357275C N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 12/26/2007 | CN100357267C Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors |
| 12/26/2007 | CN100357244C Aspirin-triggered lipid mediators |
| 12/26/2007 | CN100356979C Integrin expression inhibitors |
| 12/26/2007 | CN100356977C Regenerated human blood-platelet derivative growth factor gel |
| 12/26/2007 | CN100356965C Medicine for treating burn and scald |
| 12/26/2007 | CN100356941C External ointment for curing scald and burn |
| 12/26/2007 | CN100356934C Health-care food with spot-removing function |
| 12/26/2007 | CN100356926C Ointment medicine for treating bedsore |
| 12/26/2007 | CN100356910C Medicine composition for treating beriberi |
| 12/25/2007 | US7312344 Dimeric isoflavones |
| 12/25/2007 | US7312328 Antiinflammatory agents; autoimmune disease; rheumatic diseases; multiple sclerosis; respiratory system disorders |
| 12/25/2007 | US7312304 Somatostatin agonists |
| 12/25/2007 | US7312234 Chemokine receptor binding heterocyclic compounds |
| 12/25/2007 | US7312232 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 12/25/2007 | US7312230 Carboxylic acid derivatives as IP antagonists |
| 12/25/2007 | US7312211 Cathepsin S, K, F, L and B reversible inhibitory amidino and guanidino peptidyl compounds useful for treating autoimmune diseases, rheumatoid arthritis, multiple sclerosis, asthma and osteoporosis |
| 12/25/2007 | US7312209 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives |
| 12/25/2007 | US7312203 1H-8-oxa-1-aza-dibenzo[e,h]azulene; dual inhibitors of tumour necrosis factor(alpha) and interleukin 1; antiinflammatory, analgesics |
| 12/25/2007 | US7311905 Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
| 12/23/2007 | CA2593501A1 Partially denatured whole soybean extracts and methods of use thereof |
| 12/21/2007 | WO2007147085A2 Treatment of wound using aganocides and negative pressure |
| 12/21/2007 | WO2007146897A2 The treatment of xerostomia |
| 12/21/2007 | WO2007145306A1 Element having long blood-circulating time which is degradable selectively in tumor tissue |
| 12/21/2007 | WO2007145282A1 Therapeutic or prophylactic agent for allergic dermatitis |
| 12/21/2007 | WO2007144625A1 2-oxo-2h-chromene compounds |
| 12/21/2007 | WO2007144530A2 Free-radical-scavenger cosmetic composition |
| 12/21/2007 | WO2007144379A1 Bicyclic compounds useful as cathepsin s inbhibitors |
| 12/21/2007 | WO2007144358A1 Use of adipose-tissue cell fractions for post-irradiation tissue regeneration |
| 12/21/2007 | WO2007143897A1 A compound with special property, compositon comprising the compound and its preparation and uses |
| 12/21/2007 | WO2007143880A1 Compounds for preventing and treating bacterial infection and its preparation and use |
| 12/21/2007 | WO2007064620A3 Compositions comprising a combination of ccr5 and cxcr4 antagonists |
| 12/21/2007 | CA2835369A1 Peptide fragments for inducing synthesis of extracellular matrix proteins |
| 12/21/2007 | CA2655557A1 Method for treatment of wound using aganocides |
| 12/21/2007 | CA2655488A1 Simultaneous, separate or sequential therapeutic use of at least one botulinum neurotoxin and of at least one opiate derivative |
| 12/21/2007 | CA2655286A1 Therapeutic or prophylactic agent for allergic dermatitis |
| 12/21/2007 | CA2654021A1 Use of adipose-tissue cell fractions for post-irradiation tissue regeneration |
| 12/21/2007 | CA2650666A1 Substituted cyanopyridines as protein kinase inhibitors |
| 12/20/2007 | US20070293570 Pharmaceutical uses for alpha2delta ligands |
| 12/20/2007 | US20070293569 Pentaerythritol Derivatives and a Method for Preparation Thereof, and Liquid Crystal Base Containing the Same |
| 12/20/2007 | US20070293559 Orally Administered Agent For Preventing Or Improving Dry Station Of Skin |
| 12/20/2007 | US20070293555 4-methoxy-benzoic acid 1-imidazol-1-yl methyl-2-(4-fluorophenoxy)-ethyl ester; N-[(1-imidazol-1-yl methyl)-2-phenoxy-ethyl]-4-iodo-benzamide; cancer, inflammation, septic shock, infertility, preterm labor, pain, or an ischemia |
| 12/20/2007 | US20070293544 Novel 4-Arylamino Pyridone Derivatives as Mek Inhibitors for the Treatment of Hyper-Proliferative Disorders |
| 12/20/2007 | US20070293528 non-steroidal partial activators and/or tissue-specific activators or inhibtors for androgen receptors, used for treating acne, alopecia, hirsutism, prostatic hyperplasia or prostate cancer |
| 12/20/2007 | US20070293524 Salts, hydrates, solvatesand/or N-oxides; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors; inhibiting an Fc receptor signal transduction cascade |
| 12/20/2007 | US20070293523 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents |
| 12/20/2007 | US20070293522 2,4-pyrimidinediamine compounds and their uses |
| 12/20/2007 | US20070293521 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents |
| 12/20/2007 | US20070293520 2,4-pyrimidinediamine compounds and their uses |
| 12/20/2007 | US20070293488 tyrosine kinase inhibitors such as 1-(2-fluoro-5-trifluoromethylphenyl)-3-[4-(5-oxo-5,8-dihydropyrido[2,3-d]pyrimidin-4-ylamino)phenyl]urea, used as antitumor or anticarcinogenic agents or for the treatment of psoriasis, arthritis, retinopathy or dermatitis |